Showing results (891-900 of 1,158) with videos related to

Sort By:
Pageof 116
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 21, 2008
The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapseC D Hamilton, J E Stout, P C Goodman, et al.
Chemical Communications (Cambridge, England)|September 21, 2002
Disruption of protein-protein interactions: design of a synthetic receptor that blocks the binding of cytochrome c to cytochrome c peroxidaseY Wei, G L McLendon, A D Hamilton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 22, 2001
Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health careL R Peterson, J D Hamilton, E J Baron, et al.
Controlled Clinical Trials|February 1, 1993
Ethical dilemmas in continuing a zidovudine trial after early termination of similar trialsM S Simberkoff, P M Hartigan, J D Hamilton, et al.
The American Journal of the Medical Sciences|October 1, 1984
Nonurban male homosexuals: epidemiologic, immunologic and virologic characteristicsR J Sherertz, J E Peacock, J W Sixbey, et al.
The ISME Journal|June 2, 2025
In vitro biofilm formation by a beneficial bacterium partially predicts in planta protection against rhizosphere pathogensYang Liu, Alexandra D Gates, Zhexian Liu, et al.
Molecular Cell|April 24, 2018
Allosteric Activation Dictates PRC2 Activity Independent of Its Recruitment to ChromatinChul-Hwan Lee, Jia-Ray Yu, Sunil Kumar, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
A Case Series of Metastatic Malignant Gastrointestinal Neuroectodermal Tumors and Comprehensive Genomic Profiling Analysis of 20 CasesTaylor Kandler, Eliane Cortez, Lani Clinton, et al.
FEBS Letters|November 2, 1999
Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cellsJ L Mazet, M Padieu, H Osman, et al.
Radiation Research|September 9, 1999
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RASE Cohen-Jonathan, C Toulas, I Ader, et al.
Pageof 116